Brand-Backed ASBM Pushes Back On Biosimilar Reforms

Association Questions FDA Findings On Switching And Interchangeability

 
• By David Wallace
Large yellow arrow opposing multiple small white arrows on chalkboard
The ASBM is pushing back against recent FDA moves on biosimilars • Source: Shutterstock

More from Biosimilars

More from Products